Intrauterine levonorgestrel plus transdermal estrogen is not associated with an increase in C-reactive protein (CRP) levels

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1170, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

-blockers reduce levels of interleukin-6 (IL-6) and C-reactive protein (CRP)

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Rosiglitazone significantly decreases C-reactive protein (CRP) and matrix metalloproteinase (MMP)

By  

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

QOL effects of C-reactive protein levels in diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Relating statin therapy to C-reactive protein levels

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1597-1600

Informa Healthcare

Access to resources Recommend Favorite

Role of C Reactive Protein (CRP) in Leptin Resistance

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 609-615

Bentham Science Publishers

Access to resources Recommend Favorite